Related Experiment Videos

Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma

S Zorludemir1, B W Scheithauer, T Hirose

  • 1Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

Insights

Clear cell meningiomas are aggressive tumors with a predilection for the spine and cerebellopontine angle. Despite a benign appearance, these tumors can recur, with MIB-1 indices higher in recurring cases.

Area of Science:

  • Neuro-oncology
  • Pathology
  • Molecular Biology

Background:

  • Clear cell meningioma is a recently identified morphologic entity.
  • Its pathobiology and clinical behavior remain understudied.

Observation:

  • A study examined 14 clear cell meningiomas (7 female, 6 male, ages 9-82).
  • Tumors were located in the spine (50%), posterior fossa (21%), supratentorial (21%), and foramen magnum (7%).
  • Histology revealed clear, glycogen-rich cells with extensive hyalinization; mitoses were rare.

Findings:

  • Immunohistochemistry showed vimentin and EMA positivity (100%), S-100 and CAM 5.2 negativity.
  • Progesterone receptor staining was 77%, estrogen receptor 0%.
  • Proliferating Cell Nuclear Antigen (PCNA) and MIB-1 indices were analyzed; MIB-1 was higher in recurring tumors.
  • 11 of 12 tumors were diploid; S-phase was 4-9% (mean 6.0%).
  • Recurrence occurred in 61% of patients, with local spread or metastasis in some cases.
  • Three patients died of disease.

Implications:

  • Clear cell meningiomas are morphologically distinct and can be aggressive, especially intracranial types.
  • Recurrence is not strongly associated with mitotic activity, PCNA, S-phase, or DNA ploidy.
  • MIB-1 labeling index may serve as a predictive marker for recurrence in clear cell meningiomas.

Related Concept Videos